Search Clinical Trials
Home >  Clinical Trials & Research >  Search Clinical Trials
Print

Clinical Trials & Research

Search Clinical Trials

Clinical Trials

New Search
Title   A Phase III, Open Label Study to Evaluate the Safety and Efficacy of INSTILADRIN- (rAd-IFN/Syn3) Administered Intravesically to Patients with High Grade, BCG Unresponsive, Non-Muscle Invasive Bladder Cancer (NMIBC).
Full Title   A Phase III, Open Label Study to Evaluate the Safety and Efficacy of INSTILADRIN- (rAd-IFN/Syn3) Administered Intravesically to Patients with High Grade, BCG Unresponsive, Non-Muscle Invasive Bladder Cancer (NMIBC).
Disease/Condition   Urologic Oncology (Med Onc)
Description  

Click here for more information

Eligibility Criteria   Click here for eligibility requirements
Principal Investigator   Alexander I. Sankin
Contact Name   JoAnn Horn
Contact Email   Johor@montefiore.org
Protocol Number   IRB# 16-11-187-01
Inclusion/Notes   This information was obtained from ClinicalTrials.gov.
Status   Enrolling
Adult Clinical Trial   No
Pediatric Clinical Trial   No